Bayesian selective response‐adaptive design using the historical control
暂无分享,去创建一个
Nusrat Harun | Chunyan Liu | Mi-Ok Kim | Jane C Khoury | Joseph P Broderick | J. Broderick | Mi-Ok Kim | J. Khoury | N. Harun | Chunyan Liu
[1] Daron Acemoglu,et al. Discussion Papers , 2007 .
[2] S J Pocock,et al. The combination of randomized and historical controls in clinical trials. , 1976, Journal of chronic diseases.
[3] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[4] A. Dempster,et al. Combining Historical and Randomized Controls for Assessing Trends in Proportions , 1983 .
[5] R. Peto. Discussion of 'On the Allocation of Treatments in Sequential Medical Trials' by J.A. Bather and 'The Search for Optimality in Clinical Trials' by P. Armitage , 1985 .
[6] T. J. Mitchell,et al. Bayesian Variable Selection in Linear Regression , 1988 .
[7] L Ryan,et al. Using historical controls in the analysis of developmental toxicity data. , 1993, Biometrics.
[8] D. Berry,et al. Adaptive assignment versus balanced randomization in clinical trials: a decision analysis. , 1995, Statistics in medicine.
[9] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[10] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[11] J. Grotta,et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. , 1999, Stroke.
[12] William F. Rosenberger,et al. Optimality, Variability, Power , 2003 .
[13] D. Spiegelhalter,et al. Bayesian Approaches to Clinical Trials and Health-Care Evaluation: Spiegelhalter/Clinical Trials and Health-Care Evaluation , 2004 .
[14] Ims Study Investigators. Combined Intravenous and Intra-Arterial Recanalization for Acute Ischemic Stroke: The Interventional Management of Stroke Study , 2004, Stroke.
[15] Feifang Hu,et al. Maximizing power and minimizing treatment failures in clinical trials , 2004, Clinical trials.
[16] W. Rosenberger,et al. The theory of response-adaptive randomization in clinical trials , 2006 .
[17] C. Assaid,et al. The Theory of Response-Adaptive Randomization in Clinical Trials , 2007 .
[18] Ims Ii Trial Investigators,et al. The Interventional Management of Stroke (IMS) II Study , 2007 .
[19] Joseph P. Broderick,et al. Methodology of the Interventional Management of Stroke III Trial , 2008, International journal of stroke : official journal of the International Stroke Society.
[20] Feifang Hu,et al. Doubly adaptive biased coin designs with delayed responses , 2008 .
[21] Jing Ning,et al. Using short‐term response information to facilitate adaptive randomization for survival clinical trials , 2009, Statistics in medicine.
[22] Bradley P Carlin,et al. Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials , 2011, Biometrics.
[23] B. Freidlin,et al. Outcome--adaptive randomization: is it useful? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Joseph G Ibrahim,et al. Bayesian Meta‐Experimental Design: Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes , 2012, Biometrics.
[25] Bradley P Carlin,et al. Commensurate Priors for Incorporating Historical Information in Clinical Trials Using General and Generalized Linear Models. , 2012, Bayesian analysis.
[26] G. Yin,et al. Worth Adapting? Revisiting the Usefulness of Outcome-Adaptive Randomization , 2012, Clinical Cancer Research.
[27] Brian P Hobbs,et al. Adaptive adjustment of the randomization ratio using historical control data , 2013, Clinical trials.
[28] Joseph G Ibrahim,et al. Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome. , 2014, Biometrics.
[29] Mi-Ok Kim,et al. Outcome‐adaptive randomization for a delayed outcome with a short‐term predictor: imputation‐based designs , 2014, Statistics in medicine.
[30] Anthony O'Hagan,et al. Robust meta‐analytic‐predictive priors in clinical trials with historical control information , 2014, Biometrics.
[31] Joseph G Ibrahim,et al. Bayesian sequential meta‐analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program , 2014, Statistics in medicine.
[32] J. Kimmelman,et al. Are outcome-adaptive allocation trials ethical? , 2015, Clinical trials.
[33] G. Yule. On the Methods of Measuring Association between Two Attributes , 1912 .